Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Net Cash Flow (2025 - 2026)

Updated

Nervgen Pharma (NGEN) reported Net Cash Flow of $56.49 million for the quarter ended Jun 30, 2026, compared with $3.45 million a year earlier.

Analysis

Nervgen Pharma (NGEN) Net Cash Flow (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nervgen Pharma's Net Cash Flow came in at $54.03 million; for the year ended Dec 31, 2025, it came in at $3.12 million, down 27.7% from the prior year.

  • By year, Net Cash Flow came in at $4.32 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -1.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -2.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.94 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -4.43 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -722.00 Mn
10 Nervgen Pharma 108.50 Mn 7.38 Mn - 56.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.49 Mn
Mar 31, 2026 2.03 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 888,133.63
API Access

Nervgen Pharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NGEN&period=max&api_key=YOUR_API_KEY